IAPAM Announces its Top Aesthetic Medicine Trends for 2011
The International Association For Physicians in Aesthetic Medicine (IAPAM) has surveyed experts to develop a forecast for the top aesthetic medicine treatments for 2011.
LAS VEGAS, NV, January 20, 2011 /24-7PressRelease/ -- The International Association For Physicians in Aesthetic Medicine (IAPAM) has surveyed its membership, its medical faculty, and has consulted with numerous experts in aesthetic medicine, to develop a forecast for the top aesthetic medicine treatments or trends physicians can expect to see in 2011. Ultimately, physicians who add body transformation modalities such as minimally-invasive body shaping options or hCG for weight loss, and high income/low capital expense options such as medical grade chemical peels and physician directed skin care, will position themselves for growth in 2011.
The market for all minimally invasive procedures, from botox to laser hair removal to ultrasound fat reduction will continue to out perform surgical options in 2011. Dr. Jessica Krant, respected New York City dermatologist confirms that, "given the tight economy and a bit of a backlash against "extreme" trends in aesthetic procedures, I believe that in 2011, the new aesthetic trend will be toward how LITTLE someone can get done and achieve a refreshed, more youthful version of themselves." Consistent with this trend of "less is more," the IAPAM (http://www.iapam.com) forecasts a growth in non-invasive treatments in all aesthetic medicine arenas (botox, dermal fillers, chemical peels, lasers, microdermabrasion, and weight loss) for 2011.
1. Body Shaping Market Expands
The aesthetic medicine industry will continue to see three types of body shaping equipment utilized, but laser-assisted lipolysis will be the most effective procedure with the most dramatic results. Physicians will see the non-invasive body shaping options increase, including CoolSculpt by Zeltiq and Sound Surgical's ultrasound based VaserShape. "2011 should be the year that "Ultrashape's Countour and Medicis' Liposonix ultrasound equipment will receive FDA approval," forecasts Jeff Russell, Executive Director of the IAPAM, "and these technologies will capture a growing segment of the laser lipolysis market."
2. Medical Weight Loss Grows
People will continue to focus on their own health in 2011. "Adult obesity rates rose in 28 states over the past year," reports the annual , F as in Fat 2010 study. However, research shows that a key to long term weight loss is a high 'initial weight loss' by the patient. Therefore, hCG for weight loss is positioned to have strong growth in 2011.
First discovered by Dr. Simeons in 1954, as outlined in his manuscript, Pounds and Inches, hCG has been used for over 50 years as a weight loss aid. hCG for weight management "is not a new procedure, but one that is going to explode in 2011", predicts Jeff Russell. Administrating hCG for weight loss requires a properly trained physician (http://www.aestheticmedicinesymposium.com/physician-hcg-weight-loss-training) who has been certified in the protocols, since the long term success of doing an hCG weight loss program is only achieved by using pharmaceutical strength hCG, not homeopathic hCG which mainly contains water and alcohol.
Non-invasive body shaping equipment will also be needed for physicians offering medically supervised weight loss, since rapid weight loss programs, like hCG, usually results in loose skin and small pockets of fat that are perfect for this type of equipment. This will be the leading equipment for non-surgically trained physicians.
3. Cosmetic Injectable Choices Surge
2010 saw the addition of lidocaine to several dermal fillers, and in 2011 it is expected that two new options in the cosmetic injectable arena will be Xeomin, which received FDA approval for medical uses in 2010, and Mentor Corporation's PurTox, which is completing its FDA approvals. Moreover, Medicis' Dysport will continue to see gains over Allergan's Botox in 2011. Also, fillers will be much more utilized, not just for filling, or in the correction of a specific line or fold, but for 'face contouring', volume correction, and a lifting effect.
4. Demand for Professional Grade Skin Care Treatments Increases
When the economy started to dip, people started to eliminate more expensive, skin care products from their cabinet. After several years, consumers are seeing the price for such a decision in the mirror. Industry professionals are will see a trend toward patients turning to professional skin care lines that contain active ingredients, which are only carried by physicians. Cosmeceuticals will be the cornerstones of professional grade skin care lines. Products from industry leaders, which contain peptides, Alpha Hydroxy Acids (AHAs), antioxidants and/or caffeine, will underpin the most successful physician-directed regiments.
5. Chemical Peels and Microdermabrasion Continue Strong Growth
Chemical peels and microdermabrasion were the two fastest growing minimally-invasive procedures last year according to the ASPS, and as the baby boomer generation ages, industry experts in the IAPAM anticipate that demand for chemical peels will maintain, if not increase over 2011. With the economy still recovering, many of the more inexpensive, entry procedures, like chemical peels and microdermabrasion are becoming more popular. Chemical peels are great anti-aging and pigmentation correction treatments for issue with which most baby boomers suffer. From a profitability perspective, physicians who can meet the facial rejuvenation needs of clients with chemical peels and medical mircordermabrasion will secure more consistent cash flows and profitability for their practices.
For a complete copy of the article, IAPAM Announces the Top Aesthetic Medicine Trends for 2011, go to http://www.aestheticmedicinenews.com/iapam-announces-top-aesthetic-me ... market.htm.
For more information on the IAPAM's 2011 calender of Aesthetic Medicine Symposiums (http://www.aestheticmedicinesymposium.com), Botox Training and Injectables Training, Medical Practice Start-Up Workshops or hCG Training and Medical Weight Management Seminars, please visit http://www.iapam.com or contact Jeff Russell, Executive Director, IAPAM, at 1-800-219-5108 ext. 704, or email info@theiapam.com.
Botox is trademark of Allergan, Inc.
Press Release Contact Information:
Jeff Russell
IAPAM
Executive Director
848 N. Rainbow Blvd., #713
Las Vegas, Nevada
USA 89107
Voice: 1-800-219-5108
Fax: 1-866-284-9318
Website: Visit Our Website
